Trials Contractor Cvitkovic To Take Equity In Peplin Biotech

French-based clinical trial contractor Cvitkovic and Associates Consultants (CAC) will take equity in Brisbane cancer-drug developer Peplin Biotech (ASX:PEP) and establish a ‘dedicated operation’ in Australia.

MORE ON THIS TOPIC